Empire Genomics, founded in 2006 by Dr. Norma J. Nowak, is a leader in molecular diagnostics and genomic services. The company specializes in the design, manufacturing, and sale of Fluorescence In Situ Hybridization (FISH) probes for cancer and genetic disorder research and diagnostics. They also offer services such as Chromosomal Microarray Analysis (CMA) and Next-Generation Sequencing (NGS). Empire Genomics is committed to advancing personalized medicine by providing high-quality, customizable genomic tools and expertise to researchers, clinicians, and pharmaceutical companies worldwide. Their focus is on enabling precise and rapid detection of genetic abnormalities to improve patient outcomes.
Serves as the central hub for research and development, manufacturing of genomic probes, laboratory services, and corporate operations.
Located within the Buffalo Niagara Medical Campus (BNMC), providing access to a collaborative biomedical ecosystem and state-of-the-art research facilities. The facility houses advanced laboratories for molecular biology and cytogenetics.
A science-driven, innovative, and collaborative environment focused on precision and quality in genomic research and diagnostics. Employees are often passionate about contributing to advancements in personalized medicine.
The headquarters is strategically located in a major hub for life sciences innovation, facilitating collaborations with research institutions and hospitals. It's central to their mission of developing and delivering critical genomic tools.
Empire Genomics serves a global clientele of research institutions, clinical laboratories, and pharmaceutical companies. Their international reach is facilitated through a network of international distributors, direct sales channels, and collaborations. They support customers worldwide by providing access to their specialized FISH probes and genomic services, adapting to diverse regulatory environments and research needs across different countries.
700 Ellicott Street
Buffalo
NY
USA
Address: N/A (Represents distributed sales and support teams rather than physical offices)
To provide localized sales, technical support, and foster client relationships in key markets worldwide, adapting to regional research needs and diagnostic practices.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Empire Genomics' leadership includes:
Empire Genomics has been backed by several prominent investors over the years, including:
Based on publicly available information and news releases over the past 12 months, there have been no major announced new hires or departures at the executive level for Empire Genomics. The leadership team appears consistent.
Discover the tools Empire Genomics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Empire Genomics likely uses common professional email formats. The most probable pattern involves a combination of the employee's first initial and last name. Other formats might also be in use.
[first_initial][last]@empiregenomics.com (e.g., jsmith@empiregenomics.com)
Format
ajohnson@empiregenomics.com (Illustrative example for Anthony Johnson)
Example
75%
Success rate
Empire Genomics Website • October 20, 2023
Empire Genomics announced its participation and presentation at the AMP 2023 Annual Meeting & Expo, showcasing its latest advancements in molecular pathology and genomic solutions....more
Empire Genomics Website • July 31, 2023
Empire Genomics shared its plans to present its research and products at the CGC 2023 Annual Meeting, highlighting its contributions to cancer genomics....more
Empire Genomics Website • February 1, 2023
Empire Genomics announced the appointment of Michael L. Buisch, MBA, as its new Vice President of Business Development, bringing extensive experience to drive strategic growth and market expansion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Empire Genomics, are just a search away.